Bioinformatics News and Research

RSS

Bioinformatics is the application of information techniques for the storage, retrieval, and analysis of large quantities of biological data.

Researchers describe mathematical model as key to developing effective drugs for brain disorders

A collaboration between researchers from the UAB Institute of Neurosciences and the pharmaceutical company GlaxoSmithKline, published in March in Trends in Pharmacological Sciences, describes a mathematical model to quantify the activity of biased G-protein-coupled receptors.

28 Mar 2019

Study provides new pathway for controlling inflammation

UT Southwestern researchers have identified two proteins that act as gatekeepers to dampen a potentially life-threatening immune response to chronic infection.

22 Mar 2019

FDA chief calls for stricter scrutiny of electronic health records

Food and Drug Administration Commissioner Scott Gottlieb on Wednesday called for tighter scrutiny of electronic health records systems, which have prompted thousands of reports of patient injuries and other safety problems over the past decade.

22 Mar 2019

Novel plasmid could hold key to control of mosquito-borne illness

A team of international researchers may have identified a new way to control mosquito-borne illnesses, according to a new study published in the journal Nature Communications.

21 Mar 2019

New mobile DNA element in Wolbachia may contribute to improved disease control strategies

Controlling mosquito-borne illnesses, such as Dengue or West Nile virus, has historically been difficult due to a lack of effective vaccines and concerns about the environmental impact of insecticides.

21 Mar 2019

Latest advances and perspectives of all AI types used in pharmaceutical R&D

The advances in Artificial intelligence have successfully propagated into the many areas such as computer vision, speech recognition, and natural language processing.

19 Mar 2019

Insilico Medicine announces partnership with Master Investor

Insilico Medicine a biotechnology company specializing in the application of artificial intelligence for drug discovery, biomarker development, and aging research has announced its second year of partnership with Master Investor at the annual Master Investor Show.

From Insilico Medicine 14 Mar 2019

PNAS publishes results of pilot study for early detection of liver cancer

Today, Proceedings of the National Academy of Sciences published the results of a pilot study for early detection of liver cancer in a cohort of HBV carriers, who are at risk for developing this disease.

13 Mar 2019

DNAnexus launches innovative clinico-genomic cohort browser to accelerate research and discovery

DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the addition of an innovative browser for clinico-genomic cohorts to its DNAnexus Apollo™ Platform, allowing for easy at-scale navigation and exploration on combined genotypic and phenotypic data.

12 Mar 2019

Using TGS technology to make the perfect match even better for stem cell transplant recipients

At Anthony Nolan we save the lives of people with blood cancers and blood disorders that need a stem cell transplant.

4 Mar 2019

New approach to tackling chronic inflammatory diseases

An EU-funded project has developed new approaches to tackling chronic inflammatory diseases. These will be used to create precise and individualized treatment options, potentially leading to faster diagnosis, more effective treatments and even cures.

1 Mar 2019

Lack of diversity in cell lines does not allow minorities to reap the benefits of precision medicine

As the biomedical field races to develop therapies based on an individual's genetic makeup, a City of Hope scientist and his colleagues found that some commercial cell lines used for countless laboratory studies have mislabeled ancestry when it comes to minorities.

25 Feb 2019

Mogrify to accelerate novel IP and cell therapies using $3.7m USD funding

Mogrify today announced a second close on its seed funding, bringing the total raised to $3.7 million USD, and the appointment of Darrin Disley as CEO.

20 Feb 2019

New computational tool searches for factors that cause specific diseases

Researchers from Boston University School of Medicine have developed and tested a new computational tool, Candidate Driver Analysis, which will search for combinations of factors that are likely to cause a specific disease.

20 Feb 2019

Combination of PARP inhibitor and immunotherapy results in tumor regression in SCLC mouse models

Researchers at The University of Texas MD Anderson Cancer Center have discovered that a combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair achieved significant tumor regression in mouse models of small cell lung cancer, suggesting a promising new approach for treating patients with this aggressive cancer.

18 Feb 2019

New method for improved visualization of single-cell RNA- sequencing data

Like going from a pinhole camera to a Polaroid, a significant mathematical update to the formula for a popular bioinformatics data visualization method will allow researchers to develop snapshots of single-cell gene expression not only several times faster but also at much higher-resolution.

15 Feb 2019

Researchers study animal venoms to identify new medicines for treating diseases

Animal venoms are the subject of study at research center based at the Butantan Institute in São Paulo. But in this case, the idea is not to find antidotes, but rather to use the properties of the venoms themselves to identify molecular targets of diseases and, armed with that knowledge, develop new compounds that can be used as medicines.

15 Feb 2019

Scientists develop machine-learning approach to identify source of Salmonella

A team of scientists led by researchers at the University of Georgia Center for Food Safety in Griffin has developed a machine-learning approach that could lead to quicker identification of the animal source of certain Salmonella outbreaks.

12 Feb 2019

ALS and Tow Foundation announce their continuing support to New York Genome Center

The ALS Association and The Tow Foundation are pleased to announce their continuing support of the New York Genome Center's Center for Genomics of Neurodegenerative Disease, in recognition of the substantial genomic research being carried out by NYGC scientists.

6 Feb 2019